Randhawa Simrat: insider trades.
Randhawa Simrat reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.5M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Randhawa Simrat
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Officer · EVP, Head of R&D | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | M | 7,500 | $17.88 | 11,500 | Form 4 |
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | M | 6,249 | $21.77 | 17,749 | Form 4 |
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | M | 9,375 | $22.07 | 27,124 | Form 4 |
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | S | 2,600 | $105.19 | 24,524 | Form 4 |
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | S | 7,215 | $106.25 | 17,309 | Form 4 |
| 2026-09-01 | Dianthus Therapeutics, Inc. /DE/ | S | 13,309 | $106.74 | 4,000 | Form 4 |
Questions
What stock did Randhawa Simrat buy or sell?
Randhawa Simrat reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.5M), across 1 company.
Is Randhawa Simrat the same person as other filers with this name?
This page covers SEC CIK 1992260 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/randhawa-simrat-1992260.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.